Federal Court Invalidates Bayer’s Patent On Yasmin Birth Control Pill

A federal court in New Jersey on Monday invalidated Bayer Schering’s patent on its oral contraceptive Yasmin, ruling in favor of a challenge filed by Barr Pharmaceuticals, AFP/Google.com reports. The ruling now allows Barr to sell a generic version of Yasmin in the U.S. (AFP/Google.

More: continued here

Filed under: Medical Malpractice / Litigation on March 15th, 2008